A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)

Conditions:   Lymphoma, T-cell, Peripheral;   Lymphoma, T-cell, Cutaneous Intervention:   Drug: Remitoro Sponsor:   Eisai Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials